M-9, r. 12.3 - Regulation respecting the professional activities that may be engaged in by a medical electrophysiology technologist

Section 3 Disposition versions

2017-09-14

3. To engage in the activities described in section 2, a medical electrophysiology technologist must hold a training certificate issued by the Ordre des technologues en imagerie médicale, en radio-oncologie et en électrophysiologie médicale du Québec confirming the successful completion of training comprising the following 2 modules:

(1)  theoretical training of 17 hours offered on the training portal of the Order on

(a)  the description of contrast substances;

(b)  injection techniques;

(c)  the procedure to install an intravenous infusion;

(d)  the precautions, effects and interventions following an injection;

(e)  the monitoring of signs and symptoms related to possible complications in the patient;

(f)  adverse effects of contrast substances;

(g)  asepsis;

(h)  risk factors to be considered prior to injection; and

(i)  the volumes to be injected;

(2)  clinical training consisting in at least 15 injections of contrast substances administered independently, 3 of which including the installation of an intravenous infusion, supervised by a medical electrophysiology technologist, holding a training certificate to perform echocardiography or vascular ultrasonography and a training certificate for the activities referred to in section 2. The training may also be supervised by a medical imaging technologist or a radiation oncology technologist.

O.C. 804-2017, s. 3.

Not in force

In force: 2017-09-14

3. To engage in the activities described in section 2, a medical electrophysiology technologist must hold a training certificate issued by the Ordre des technologues en imagerie médicale, en radio-oncologie et en électrophysiologie médicale du Québec confirming the successful completion of training comprising the following 2 modules:

(1)  theoretical training of 17 hours offered on the training portal of the Order on

(a)  the description of contrast substances;

(b)  injection techniques;

(c)  the procedure to install an intravenous infusion;

(d)  the precautions, effects and interventions following an injection;

(e)  the monitoring of signs and symptoms related to possible complications in the patient;

(f)  adverse effects of contrast substances;

(g)  asepsis;

(h)  risk factors to be considered prior to injection; and

(i)  the volumes to be injected;

(2)  clinical training consisting in at least 15 injections of contrast substances administered independently, 3 of which including the installation of an intravenous infusion, supervised by a medical electrophysiology technologist, holding a training certificate to perform echocardiography or vascular ultrasonography and a training certificate for the activities referred to in section 2. The training may also be supervised by a medical imaging technologist or a radiation oncology technologist.

O.C. 804-2017, s. 3.